ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

83
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
bullishNongfu Spring
06 Jan 2021 13:53

Full Circulation Of H-Shares: January 2021 Update

To date, 20 companies have sought approval to convert their domestic shares into H shares,  13 of which have now been given CSRC and Hong Kong...

Logo
450 Views
Share
17 Jul 2020 12:49

Full Circulation Of H-Shares - July Update

This update is the latest in a series dating back to Legend's Conversion of Domestic Shares in June 2018, with the most recent addition CPPCC And...

Logo
570 Views
Share
21 May 2020 16:47

CPPCC And Full Circulation Of H-Shares

After being delayed two months, the 2020 National People's Congress and Chinese People's Political Consultative began its annual session today,...

Logo
318 Views
Share
08 May 2020 10:04

Hong Kong Buyback League Table: Evergrande, Yichang HEC, Yanzhou Coal

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
330 Views
Share
20 Jan 2020 09:33

Hong Kong Buyback Weekly: Xingyi Glass, Yichang HEC, Consun Pharma

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
330 Views
Share
x